DashboardWarning LettersWarning Letter Details

ABBE Laboratories, Inc. Warning Letter Details

Warning Letter
View Letter

ABBE Laboratories, Inc.

Issue DateAugust 06, 2025
FEI NumberN/A
Violations3
CountryN/A
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

ABBE Laboratories, Inc. FDA Warning Letter, August 6, 2025